Jenn BashamAssociate News EditorThe Food and Drug Administration recently added a black box warning to Depo-Provera, the popular injection contraceptive, after studies revealed that prolonged use of ...

Pfizer (NYSE:PFE) is facing an increasing number of lawsuits in the U.S. over its alleged failure to warn that its Depo-Provera contraceptive injection for women can cause a brain tumor called ...

The recent decision by the U.S. Judicial Panel on Multidistrict Litigation (JPML) to consolidate Depo-Provera lawsuits into MDL No. 3140 in the Northern District of Florida marks a critical step ...

Pfizer Inc. (NYSE: PFE) faces mounting legal challenges over claims that its contraceptive injection Depo-Provera (DMPA) is linked to brain tumors, with a key court hearing set for late September that ...

If you have questions about filing a Depo-Provera lawsuit, you are not alone. As awareness of the link between Depo-Provera and intracranial meningioma continues to grow, we are continuing to hear ...

Since the beginning of the year, there has been a rise in the number of lawsuits against pharma giant Pfizer over its injectable contraception, Depo-Provera. Consumers have increasingly joined ...

CHICAGO, Aug 25 (Reuters) - Pfizer has urged a Florida federal judge to dismiss lawsuits claiming its birth control shot Depo-Provera can cause users to develop a type of brain tumor, saying ...

At a Friday hearing, U.S. District Judge M. Casey Rodgers, of the Northern District of Florida, told lawyers that although there were now 932 lawsuits filed over Depo-Provera, another 9,571 remained ...

New US peer-reviewed study adds to body of research confirming link between use of Depo-Provera and increased risk of brain tumours One of the law firms appointed to the Plaintiff’s Executive ...

New US peer-reviewed study adds to body of research confirming link between use of Depo-Provera and increased risk of brain tumours A hearing in the Depo-Provera legal action against Pfizer Inc. (NYSE ...

PENSACOLA, Fla.--(BUSINESS WIRE)--A Case Management Conference (CMC) in the Depo-Provera legal action against Pfizer Inc. (NYSE:PFE) will take place on Friday, 30 May at 9:00am CT in the United States ...